This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Chernesky, M. A. Articles by Schachter, J. Search for Related Content PubMed PubMed Citation Articles by Chernesky, M. A. Articles by Schachter, J.

 Previous Article  |  Next Article 

Journal of Clinical Microbiology, January 2005, p. 127-131, Vol. 43, No. 1
0095-1137/05/$08.00+0     doi:10.1128/JCM.43.1.127-131.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.

Ability of New APTIMA CT and APTIMA GC Assays To Detect Chlamydia trachomatis and Neisseria gonorrhoeae in Male Urine and Urethral Swabs

St. Joseph's Healthcare, Hamilton, Ontario, Canada,¹ Louisiana State University Health Sciences Center, New Orleans, Louisiana,² University of Alabama, Birmingham, Alabama,³ Florida State Department of Health, Jacksonville, Florida,⁴ Magee Women's Research Institute, Pittsburgh, Pennsylvania,⁵ Gen-Probe Incorporated, San Diego,⁶ University of California, San Francisco, California,⁸ Wishard Memorial Hospital, Indianapolis, Indiana⁷

Received 28 April 2004/ Returned for modification 22 July 2004/ Accepted 22 September 2004

A clinical evaluation was conducted in six North American centers to determine the ability of APTIMA CT (ACT) and APTIMA GC (AGC) nucleic acid amplification assays to detect Chlamydia trachomatis and Neisseria gonorrhoeae infections in 1,322 men by testing their urethral swabs and first-catch urine (FCU). The results obtained with ACT and AGC assays were compared to an infected patient status determined by testing the specimens with the APTIMA Combo 2 and the BD ProbeTec energy transfer multiplex assays. Symptoms did not influence the values. Positive and negative agreements of the ACT and AGC assays for individual specimens were high, with each comparator assay ranging between 94.3 and 100% for positives and 93.9 and 99.4% for negatives. The ACT and AGC assays performed on noninvasive specimens such as FCU effectively identified C. trachomatis or N. gonorrhoeae infections in symptomatic and asymptomatic men and should be suitable for screening male populations.

This article has been cited by other articles:

• Palmer, H M, Young, H, Graham, C, Dave, J (2008). Prediction of antibiotic resistance using Neisseria gonorrhoeae multi-antigen sequence typing. Sex. Transm. Infect. 84: 280-284 [Abstract] [Full Text]  
• Moncada, J., Donegan, E., Schachter, J. (2008). Evaluation of CDC-Recommended Approaches for Confirmatory Testing of Positive Neisseria gonorrhoeae Nucleic Acid Amplification Test Results. J. Clin. Microbiol. 46: 1614-1619 [Abstract] [Full Text]  
• Michel, C.-E. C., Sonnex, C., Carne, C. A., White, J. A., Magbanua, J. P. V., Nadala, E. C. B. Jr., Lee, H. H. (2007). Chlamydia trachomatis Load at Matched Anatomic Sites: Implications for Screening Strategies. J. Clin. Microbiol. 45: 1395-1402 [Abstract] [Full Text]  
• Shahmanesh, M, Radcliffe, K W (2007). Is the urethral smear necessary in asymptomatic men attending a genitourinary medicine clinic?. Sex. Transm. Infect. 83: 79-81 [Full Text]  
• Yang, J. L, Schachter, J., Moncada, J., Habte, D., Zerihun, M., House, J. I, Zhou, Z., Hong, K. C, Maxey, K., Gaynor, B. D, Lietman, T. M (2007). Comparison of an rRNA-based and DNA-based nucleic acid amplification test for the detection of Chlamydia trachomatis in trachoma. Br. J. Ophthalmol. 91: 293-295 [Abstract] [Full Text]  
• Jaton, K., Bille, J., Greub, G. (2006). A novel real-time PCR to detect Chlamydia trachomatis in first-void urine or genital swabs.. J Med Microbiol 55: 1667-1674 [Abstract] [Full Text]  
• Lum, G., Garland, S. M., Tabrizi, S., Harnett, G., Smith, D. W., Sloots, T. P., Whiley, D. M., Tapsall, J. W., Lowe, P., O'Loughlin, P., Bartley, P. B., Vohra, R., Evans, K., White, M. (2006). Supplemental Testing Is Still Required in Australia for Samples Positive for Neisseria gonorrhoeae by Nucleic Acid Detection Tests.. J. Clin. Microbiol. 44: 4292-4294 [Full Text]